FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

8156611000001103: Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
29622101000001112 Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
112398601000001119 Zomig Rapimelt 5mg orodispersible tablets (Grunenthal Ltd) 6 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Is a Zolmitriptan 5mg orodispersible tablets 6 tablet true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Is pack of Zomig Rapimelt 5mg tablets (AstraZeneca) false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has active ingredient Zolmitriptan false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has AMP Zomig Rapimelt 5mg tablets (AstraZeneca) true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zomig Rapimelt 5mg tablets (AstraZeneca) 6 tablet Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start